Lynx1 Capital Management LP purchased $206K of PASG (indirect holdings)
Lynx1 Capital Management LP purchased 50,055 indirectly-held shares of Passage BIO, Inc. (PASG) at $4.12 ($0.21M total) on 2026-06-25.
How this was made
The 30-second read
Why it matters
The newest fact is Lynx1 Capital Management LP’s open-market purchase of 50,055 shares at $4.1175, bringing holdings to 673,759 shares (indirect).
Market read
Traders may treat the filing as a small sentiment input, but it does not replace fundamental catalysts (earnings, guidance, trials, deals).
What to watch
No 10b5-1 plan and the transaction is indirect; without context on prior buys/sells or total position changes, signal strength is limited.
Background
The article is an SEC Form 4 insider transaction disclosure for Passage BIO, Inc. (PASG).
Ticker impact
Passage BIO disclosed via Form 4 that Lynx1 Capital Management LP bought 50,055 shares of PASG at $4.1175 on 2026-06-25.
Likely limited near-term impact; any effect would be incremental and fade unless followed by additional disclosures or company-specific news.
The filing is primary-source and specific (shares, price, date), but it is an insider/owner transaction without accompanying operational or guidance changes.
Market effects
No clear sector read-through; this is company-specific ownership activity.
None indicated.
None indicated.
Counterpoint
The purchase may be routine portfolio rebalancing or indirect holdings mechanics rather than a strong bullish thesis.
Key entities
- issuerPassage BIO, Inc.
Company whose shares (PASG) were purchased; subject of the Form 4 disclosure.
- 10% ownerLynx1 Capital Management LP
Reporter of the Form 4 transaction; executed an open-market purchase on 2026-06-25.
